Gel Based on Hydroxyethyl Starch with Immobilized Amikacin for Coating of Bone Matrices in Experimental Osteomyelitis Treatment-Reference-Cited by-同舟云学术

Gel Based on Hydroxyethyl Starch with Immobilized Amikacin for Coating of Bone Matrices in Experimental Osteomyelitis Treatment

Published:2023-11-13 Issue:12 Volume:24 Page:5666-5677
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Luss Anna¹²^ORCID,Kushnerev Kirill¹²,Vlaskina Elizaveta²,Vanyushenkova Anna²,Mezhuev Yaroslav O.²³,Krivoborodov Efrem²,Toropygin Ilya⁴,Gavryushenko Nikolai⁵,Vetrile Marchel⁵,Zaitsev Vladimir⁵,Dyatlov Valerie²⁶

Affiliation:

1. Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency, Moscow 119121, Russia

2. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia

3. A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Moscow 119334, Russia

4. V. N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Science, Moscow 119121, Russia

5. N. N. Priorov National Medical Research Center for Traumatology and Orthopedics, Ministry of Health of Russia, Moscow 115478, Russia

6. MIREA-RTU−Lomonosov Institute of Fine Chemical Technologies, Moscow 119571, Russia

Funder

Ministry of Science and Higher Education of the Russian Federation

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.3c00653

Reference58 articles.

1. Bone substitutes in orthopaedic surgery: from basic science to clinical practice

2. Less Invasive Surgery With Autologous Bone Grafting for Proximal Fifth Metatarsal Diaphyseal Stress Fractures

3. Prospective, randomized, double-blinded clinical trial comparing PEEK and allograft spacers in patients undergoing transforaminal lumbar interbody fusion surgeries

4. Allografts

5. Maxillary sinus augmentation using xenogenic bone substitute material Bio-Oss® in combination with venous blood